Home
>
National Drug Code (NDC)
>
Moexipril hydrochloride
Moexipril hydrochloride - 16252-611-01 - (Moexipril hydrochloride)
Drug Information of Moexipril hydrochloride
| Product NDC: | 16252-611 |
| Proprietary Name: | Moexipril hydrochloride |
| Non Proprietary Name: | Moexipril hydrochloride |
| Active Ingredient(s): | 15 mg/1 & nbsp; Moexipril hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Moexipril hydrochloride
| Product NDC: | 16252-611 |
| Labeler Name: | Cobalt Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020312 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20061215 |
Package Information of Moexipril hydrochloride
| Package NDC: | 16252-611-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (16252-611-01) |
NDC Information of Moexipril hydrochloride
| NDC Code | 16252-611-01 |
| Proprietary Name | Moexipril hydrochloride |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (16252-611-01) |
| Product NDC | 16252-611 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Moexipril hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20061215 |
| Marketing Category Name | NDA |
| Labeler Name | Cobalt Laboratories |
| Substance Name | MOEXIPRIL HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
